Breaking the monopoly of "foreign strains" of infants and young children, progress has been made in the localization of Chinese infant probiotic strains

On April 25, the National Health Commission announced that the No.

It is understood that MP108 was isolated from the intestines of healthy infants and young children in China.

At present, MP108 has published 3 patents and 9 academic papers, including 2 published by SCI.

"One side of the water and soil raises one side of good bacteria".

With the change of parenting concepts, more and more mother and infant families in China realize that probiotics are closely related to the health of their babies.

Data shows that in the past five years, China's probiotics industry has developed rapidly at an annual growth rate of more than 15%, and the market is still in a period of rapid growth

However, the main market share of the domestic probiotic raw material supply market is still occupied by foreign manufacturers.

"Strain localization" is bringing out the new vitality of China's probiotics industry, helping Chinese enterprises to overtake in the golden age of probiotics health food

(Yang Xiaojing)

Responsible editor: Zhao Yangyi Review: Zheng Ying